Pappas Capital has raised $85.8 million toward a venture-capital fund, according to a filing with the SEC.
A. M. Pappas Life Science Ventures V attracted capital from 29 LPs.
Study participants will use emocha’s platform to video record themselves each day for 24 weeks as they take buprenorphine.
While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some.
As 9,000 official badge holders—alongside what could feel like three times as many unofficial attendees—swarmed downtown San Francisco for the annual J.P. Morgan Healthcare Conference, much of the opening small talk in the hastily bedless hotel suites-turned-meeting rooms began with, “Can you believe some of these prices?”
BIO, in partnership with the American Seed Trade Association (ASTA), is proud to announce today that we are launching Innovature, an initiative to engage people in a dialogue on the promise of innovation in food and agriculture and the tangible benefits it brings to our planet, our health, and our food.
The goal of Innovature is to grow awareness, acceptance and adoption of gene editing in food and agriculture, and seed positive ground for future innovations that address some of society’s most pressing challenges, such as climate change, hunger and sustainability.
Popper and Co., a strategy consulting and transaction advisory firm guiding medical technology and life sciences companies working on the leading-edge of diagnostics and patient management, announced today the addition of Vincent Linder, PhD and Gene Vivino to its growing team of industry and clinical senior advisors. Both Dr. Linder and Mr. Vivino provide strong industry knowledge and extensive operating experience, in addition to broad networks in both Europe and Asia.
To date, the conversation around CAR-T cell therapies in cancers has focused on the most visible considerations: efficacy, toxicity and cost. But while those factors are important, another one deserves equal consideration: manufacturing.
Join us for the January 23, 2019 for PATHFINDER INNOVATION PROGRAM
Learn more about:
- Overview and Reporting Requirements for Type of Entity
- Impact of Accounting Methods
- Start-up Company Issues
- International Investment
- Tax Law Changes
- State Tax Concerns
- Tax Planning
Schedule
12:00 p.m – Networking Lunch
12:30 – 1:30 p.m. – Discussion with Q&A* – Tom Christiana, Partner – Aronson, LLC
1:30 – 4:00 p.m. – One-on-one Meetings**
RSVP by noon, January 22, at BHI@BioHealthInnovation.org
No charge to attend but pre-registration is required.*Attend in person (1 Church St, Rockville) or by videoconference**Attendance at discussion is required to participate in 1:1
Montgomery beat out Boston and the Philadelphia areas to win the project.
BioHealth Innovation, Inc. (BHI) announced today that John P. Sullivan has joined BHI as a new Entrepreneur-in-Residence (EIR) for the National Institutes of Health (NIH), working with Ethel Rubin, PhD, ventures team head, to provide product, corporate and private investment strategy for NIH portfolio companies.
“We are pleased to have Mr. Sullivan join the team of EIRs serving NIH,” said Richard Bendis, BHI President and CEO. “His expertise in building, operating and acquiring health technology businesses will certainly be an asset as he works to provide the institution with industry insights and commercialization perspectives.”
Established with NIH in 2012, the EIR program is designed to connect NIH-funded start-ups with experienced industry experts who can help them maneuver through multi-disciplinary technical challenges and the business and regulatory environment to deploy new healthcare and biomedical technologies.
A sign of the BioHealth Capital Region’s industry growth is the increase in hiring taking place throughout the region. More than 1800 job opportunities are listed on BioHealth Innovation’s website (www.BioHealthInnovation.org/Jobs). Many with relatively young companies expanding their regulatory, manufacturing and R&D teams. To post positions, Email: BHI@BioHealthInnovation.org.